Advanced search
Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 50, 2020 - Issue 6
Submit an article Journal homepage
357
Views
15
CrossRef citations to date
0
Altmetric
ARTICLES

Facile synthesis and anti-proliferative activity evaluation of quinoxaline derivatives

Jin LinFujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou, China; ORCID Iconhttp://orcid.org/0000-0003-1595-9161View further author information
ORCID Icon,
Panpan WangSchool of Pharmacy, Fujian Medical University, Fuzhou, ChinaView further author information
,
Zemin ZhangSchool of Pharmacy, Fujian Medical University, Fuzhou, ChinaView further author information
,
Guozhen XueSchool of Pharmacy, Fujian Medical University, Fuzhou, ChinaView further author information
,
Daijun ZhaSchool of Pharmacy, Fujian Medical University, Fuzhou, ChinaView further author information
,
Jian WangSchool of Pharmacy, Fujian Medical University, Fuzhou, ChinaView further author information
,
Xiuzhi XuSchool of Pharmacy, Fujian Medical University, Fuzhou, ChinaView further author information
&
Zhulai LiSchool of Pharmacy, Fujian Medical University, Fuzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 823-830 | Received 06 Oct 2019, Published online: 23 Jan 2020

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Premkumar B. Thombre, Sonali A. Korde, Sudarshan S. Dipake, Anjali S. Rajbhoj, Machhindra K. Lande & Suresh T. Gaikwad. (2023) A rapid synthesis of quinoxalines by using Al2O3–ZrO2 as heterogeneous catalyst. Synthetic Communications 53:19, pages 1623-1636.
Read now
Mayada E. G. Elsakka, Mohamed M. Tawfik, Lamiaa A. A. Barakat & Mohamed S. Nafie. A quinoxaline-based derivative exhibited potent and selective anticancer activity with apoptosis induction in PC-3 cells through Topo II inhibition. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now

Articles from other publishers (13)

Seyedeh Roya Alizadeh, Pourya Biparva & Mohammad Ali Ebrahimzadeh. (2024) A novel quinoxaline-based multifunctional probe: Sensitive and selective naked-eye detection of Fe3+ and fluorescent sensing of Cu2+ and its application. Arabian Journal of Chemistry 17:4, pages 105724.
Crossref
Siti Nurshahira Mohd Radzuan, Lacksany Phongphane, Mohamad Hafizi Abu Bakar, Mohammad Tasyriq Che Omar, Nor Shafiqah Nor Shahril, Unang Supratman, Desi Harneti, Habibah A. Wahab & Mohamad Nurul Azmi. (2024) Synthesis, biological activities, and evaluation molecular docking-dynamics studies of new phenylisoxazole quinoxalin-2-amine hybrids as potential α-amylase and α-glucosidase inhibitors. RSC Advances 14:11, pages 7684-7698.
Crossref
Fatma K. Abdelwadoud, Gehad S. Gomaa & Ahmed A. Geies. (2023) Synthesis and characterizations of some new selenolo[2,3‐ b ]quinoxaline derivatives . Journal of Heterocyclic Chemistry 61:1, pages 178-187.
Crossref
Mohamed F. Zayed. (2023) Chemistry, Synthesis, and Structure Activity Relationship of Anticancer Quinoxalines. Chemistry 5:4, pages 2566-2587.
Crossref
Natalia Levin, Lisa Goclik, Henrik Walschus, Neha Antil, Alexis Bordet & Walter Leitner. (2023) Decarboxylation and Tandem Reduction/Decarboxylation Pathways to Substituted Phenols from Aromatic Carboxylic Acids Using Bimetallic Nanoparticles on Supported Ionic Liquid Phases as Multifunctional Catalysts. Journal of the American Chemical Society 145:41, pages 22845-22854.
Crossref
Lacksany Phongphane, Siti Nurshahira Mohd Radzuan, Mohamad Hafizi Abu Bakar, Mohammad Tasyriq Che Omar, Unang Supratman, Desi Harneti, Habibah A. Wahab & Mohamad Nurul Azmi. (2023) Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic. Computational Biology and Chemistry 106, pages 107938.
Crossref
Mostafa A. Ismail, Moustafa S. Abusaif, Mohamed S. A. El-Gaby, Yousry A. Ammar & Ahmed Ragab. (2023) A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5- b ]quinoxaline derivatives hybrid with a sulfonamide moiety . RSC Advances 13:18, pages 12589-12608.
Crossref
Shefali Chowdhary, Asif Raza, Pule Seboletswe, Nosipho Cele, Arun K. Sharma, Parvesh Singh & Vipan Kumar. (2023) Cu-promoted synthesis of Indolo[2,3-b]quinoxaline-Mannich adducts via three-component reaction and their anti-proliferative evaluation on colorectal and ovarian cancer cells. Journal of Molecular Structure 1275, pages 134627.
Crossref
Younes Ouzidan, Betül Şen Yüksel, Yassir Filali Baba, Baraa Hafez, Youssef Kandri Rodi, Fouad Ouazzani Chahdi, Joel T. Mague, Ahmed El Hakmaoui, Mohamed Safi, Mohamed Akssira, El Mokhtar Essassi & Hicham Elmsellem. (2022) Synthesis, crystal structure, DFT calculations and Hirshfeld surface analysis of new 2-oxo-1,2-dihydroquinoline-4-carboxylate derivative. Chemical Data Collections 41, pages 100902.
Crossref
Zahra Hashemi, Mohammad Ali Ebrahimzadeh & Pourya Biparva. (2022) Naked Eye Chemosensor and In Vivo Chelating Activity of Iron (III) By Bromopyridine Quinoxaline (BPQ). Journal of Fluorescence 32:5, pages 1669-1678.
Crossref
Yasmin M. Syam, Manal M. Anwar, Somaia S. Abd El-Karim, Khaled M. Elokely & Sameh H. Abdelwahed. (2022) New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational Studies. Molecules 27:15, pages 4924.
Crossref
Suresh Kumar Suthar, Narendra Singh Chundawat, Girdhar Pal Singh, José M. Padrón & Yuvraj Kunwar Jhala. (2022) Quinoxaline: A comprehension of current pharmacological advancement in medicinal chemistry. European Journal of Medicinal Chemistry Reports 5, pages 100040.
Crossref
Xiaohua Sun, Lijun Feng, Chuance Sun & Congmin Kang. (2021) Synthesis of Quinoxaline Derivatives as Intermediates to Obtain Erdafitinib. Pharmaceutical Chemistry Journal 55:9, pages 951-953.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.